Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 534

1.

Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens.

McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S.

Transplantation. 2004 Aug 15;78(3):475-80.

PMID:
15316379
2.

Early sirolimus therapy in renal transplant recipients at high risk: is it justified?

Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Al-Waheeb S, Hasaneen H, Awadain WH, Nawas KM, El-Sayed A, Said T, Nair MP, Nampoory MR.

Transplant Proc. 2009 Sep;41(7):2784-8. doi: 10.1016/j.transproceed.2009.07.015.

PMID:
19765435
4.

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF; Sirolimus CONVERT Trial Study Group.

Transplantation. 2009 Jan 27;87(2):233-42. doi: 10.1097/TP.0b013e3181927a41.

PMID:
19155978
5.

Sirolimus: a single center experience in combination with calcineurin inhibitors.

Masterson R, Leikis M, Perkovic V, Nicholls K, Walker R.

Transplant Proc. 2003 May;35(3 Suppl):99S-104S.

PMID:
12742476
6.

Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.

Stephany BR, Augustine JJ, Krishnamurthi V, Goldfarb DA, Flechner SM, Braun WE, Hricik DE, Dennis VW, Poggio ED.

Transplantation. 2006 Aug 15;82(3):368-74.

PMID:
16906035
8.

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.

Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.

Nephrol Dial Transplant. 2005 Nov;20(11):2517-23. Epub 2005 Jun 28.

PMID:
15985508
9.

Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.

Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.

Transplantation. 2008 Apr 15;85(7 Suppl):S3-9. doi: 10.1097/TP.0b013e318169c29e.

PMID:
18401260
10.

Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.

Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.

Clin Transplant. 2004;18 Suppl 12:61-6.

PMID:
15217410
11.
12.

New approaches to de novo immunosuppression and steroid elimination.

Lebranchu Y.

Transplant Proc. 2009 Jul-Aug;41(6 Suppl):S39-41. doi: 10.1016/j.transproceed.2009.06.160. Epub 2009 Jul 17.

PMID:
19651295
13.

Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.

Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS.

Transplantation. 2007 Aug 27;84(4):467-74.

PMID:
17713429
14.

Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.

Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.

Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x.

PMID:
18199109
15.
16.

Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.

Boratyńska M, Banasik M, Patrzalek D, Szyber P, Klinger M.

Transplant Proc. 2005 Mar;37(2):839-42.

PMID:
15848550
17.

Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure.

Carmellini M, Collini A, Ruggieri G, Garosi G, Bernini M.

Transplant Proc. 2008 Jul-Aug;40(6):1858-61. doi: 10.1016/j.transproceed.2008.05.047.

PMID:
18675070
18.
19.

Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.

Steigerwalt SP, Brar N, Dhungel A, Butcher D, Steigerwalt S, El-Ghouroury M, Provenzano R.

Transplant Proc. 2009 Dec;41(10):4184-7. doi: 10.1016/j.transproceed.2009.07.109.

PMID:
20005365
20.

Supplemental Content

Support Center